Variables No. of Years After Diagnosis 0 1 2 3 4 5 6 7 8 9 10 Adenocarcinoma NOS and other specific adenocarcinomas lx 29,872 12,585 7,833 5,933 4,327 3,250 2,479 1,814 1,334 945 630 qx 57.74 37.48 23.94 17.39 13.90 11.02 11.38 10.59 9.60 9.90 7.30 Sx 42.26 26.42 20.09 16.60 14.29 12.72 11.27 10.08 9.11 8.21 7.60 Bronchioloalveolar carcinoma lx 2,684 1,890 1,532 1,320 1,032 793 625 475 363 269 184 qx 29.42 18.85 13.47 10.70 11.08 9.79 10.51 8.68 7.00 9.70 9.80 Sx 70.58 57.28 49.56 44.25 39.35 35.50 31.77 29.01 26.97 24.37 22.00 Papillary adenocarcinoma lx 688 397 265 198 140 107 80 59 43 31 18 qx 42.18 33.25 24.62 22.11 16.36 13.93 8.28 12.84 Sx 57.82 38.59 29.09 22.66 18.95 16.31 14.96 13.04 11.09 9.81 8.50 Adenosquamous carcinoma lx 1,516 762 493 377 289 222 174 133 99 66 38 qx 49.64 34.65 23.35 15.00 12.13 11.88 11.66 12.15 15.60 Sx 50.36 32.91 25.23 21.44 18.84 16.60 14.67 12.89 10.87 8.79 8.20 Squamous-cell carcinoma lx 29,931 12,942 7,544 5,429 3,970 2,982 2,247 1,667 1,220 858 567 qx 56.63 41.55 27.76 18.67 14.98 14.11 13.09 12.23 13.10 11.00 10.10 Sx 43.37 25.35 18.31 14.89 12.66 10.87 9.45 8.30 7.21 6.41 5.80 Small-cell carcinoma lx 20,172 6,956 2,332 1,416 936 672 503 360 242 159 98 qx 65.41 66.34 38.76 24.48 14.21 14.96 13.81 13.91 16.90 13.80 20.50 Sx 34.59 11.64 7.13 5.39 4.62 3.93 3.39 2.92 2.42 2.09 1.70 Large-cell carcinoma lx 10,420 3,489 1,966 1,440 1,046 799 619 489 369 259 172 qx 66.41 43.45 26.40 18.74 14.20 10.05 10.60 9.97 10.30 10.60 11.90 Sx 33.59 18.99 13.98 11.36 9.75 8.77 7.84 7.06 6.33 5.66 5.00

^* Data source: SEER, 1983 to 1992 diagnosis period with follow-up through 1995. lx = No. of patients alive at the start of the year; qx = estimated probability of dying in the year given alive at the start; Sx = estimated cumulative probability of survival to the end of the year.

Estimate not reported because the standard error of the survival probability was 5%.